nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNB2—Alzheimer's disease	0.178	0.487	CbGaD
Varenicline—CHRNA6—Galantamine—Alzheimer's disease	0.133	0.299	CbGbCtD
Varenicline—CHRNB2—Galantamine—Alzheimer's disease	0.133	0.299	CbGbCtD
Varenicline—CHRNA7—Alzheimer's disease	0.105	0.285	CbGaD
Varenicline—CHRNA4—Alzheimer's disease	0.0836	0.228	CbGaD
Varenicline—CHRNA3—Galantamine—Alzheimer's disease	0.0638	0.144	CbGbCtD
Varenicline—CHRNA4—Galantamine—Alzheimer's disease	0.0382	0.086	CbGbCtD
Varenicline—CHRNA7—Galantamine—Alzheimer's disease	0.0382	0.086	CbGbCtD
Varenicline—CHRFAM7A—Galantamine—Alzheimer's disease	0.0382	0.086	CbGbCtD
Varenicline—CHRNA4—telencephalic ventricle—Alzheimer's disease	0.0027	0.103	CbGeAlD
Varenicline—CHRNA6—forebrain—Alzheimer's disease	0.00196	0.0748	CbGeAlD
Varenicline—CHRNA6—telencephalon—Alzheimer's disease	0.00181	0.0688	CbGeAlD
Varenicline—CHRNB2—forebrain—Alzheimer's disease	0.00113	0.043	CbGeAlD
Varenicline—CHRNA3—forebrain—Alzheimer's disease	0.00109	0.0417	CbGeAlD
Varenicline—CHRNA6—nervous system—Alzheimer's disease	0.00107	0.0406	CbGeAlD
Varenicline—CHRNB2—telencephalon—Alzheimer's disease	0.00104	0.0395	CbGeAlD
Varenicline—CHRNA6—central nervous system—Alzheimer's disease	0.00103	0.0391	CbGeAlD
Varenicline—CHRNA6—cerebellum—Alzheimer's disease	0.001	0.0382	CbGeAlD
Varenicline—CHRFAM7A—forebrain—Alzheimer's disease	0.000885	0.0337	CbGeAlD
Varenicline—CHRNA6—brain—Alzheimer's disease	0.000815	0.031	CbGeAlD
Varenicline—CHRFAM7A—telencephalon—Alzheimer's disease	0.000814	0.031	CbGeAlD
Varenicline—CHRNA7—forebrain—Alzheimer's disease	0.000715	0.0272	CbGeAlD
Varenicline—CHRNA4—forebrain—Alzheimer's disease	0.000705	0.0268	CbGeAlD
Varenicline—CHRNA7—telencephalon—Alzheimer's disease	0.000657	0.025	CbGeAlD
Varenicline—CHRNA4—telencephalon—Alzheimer's disease	0.000648	0.0247	CbGeAlD
Varenicline—CHRNB2—nervous system—Alzheimer's disease	0.000613	0.0233	CbGeAlD
Varenicline—CHRNA3—nervous system—Alzheimer's disease	0.000594	0.0226	CbGeAlD
Varenicline—CHRNB2—central nervous system—Alzheimer's disease	0.00059	0.0225	CbGeAlD
Varenicline—CHRNB2—cerebellum—Alzheimer's disease	0.000576	0.0219	CbGeAlD
Varenicline—CHRNA3—central nervous system—Alzheimer's disease	0.000572	0.0218	CbGeAlD
Varenicline—CHRNA3—cerebellum—Alzheimer's disease	0.000559	0.0213	CbGeAlD
Varenicline—CHRFAM7A—nervous system—Alzheimer's disease	0.00048	0.0183	CbGeAlD
Varenicline—CHRNB2—brain—Alzheimer's disease	0.000468	0.0178	CbGeAlD
Varenicline—CHRFAM7A—central nervous system—Alzheimer's disease	0.000463	0.0176	CbGeAlD
Varenicline—CHRNA3—brain—Alzheimer's disease	0.000454	0.0173	CbGeAlD
Varenicline—CHRNA7—nervous system—Alzheimer's disease	0.000388	0.0148	CbGeAlD
Varenicline—CHRNA4—nervous system—Alzheimer's disease	0.000383	0.0146	CbGeAlD
Varenicline—CHRNA7—central nervous system—Alzheimer's disease	0.000374	0.0142	CbGeAlD
Varenicline—CHRNA4—central nervous system—Alzheimer's disease	0.000369	0.014	CbGeAlD
Varenicline—CHRFAM7A—brain—Alzheimer's disease	0.000367	0.014	CbGeAlD
Varenicline—CHRNA4—cerebellum—Alzheimer's disease	0.00036	0.0137	CbGeAlD
Varenicline—CHRNA7—brain—Alzheimer's disease	0.000297	0.0113	CbGeAlD
Varenicline—CHRNA4—brain—Alzheimer's disease	0.000293	0.0111	CbGeAlD
Varenicline—CHRNA4—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000114	0.00173	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000113	0.00172	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—SLC18A3—Alzheimer's disease	0.000113	0.00171	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.000111	0.00169	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GRIK1—Alzheimer's disease	0.00011	0.00167	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CHRNA7—Alzheimer's disease	0.00011	0.00167	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000109	0.00165	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000108	0.00164	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000107	0.00163	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—SLC18A3—Alzheimer's disease	0.000107	0.00162	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.000107	0.00162	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.000107	0.00162	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000107	0.00162	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CHAT—Alzheimer's disease	0.000107	0.00162	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GRIK2—Alzheimer's disease	0.000107	0.00162	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000106	0.00161	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000105	0.00159	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.000105	0.00159	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000104	0.00157	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000104	0.00157	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000104	0.00157	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000104	0.00157	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000104	0.00157	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CST3—Alzheimer's disease	0.000103	0.00156	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000102	0.00155	CbGpPWpGaD
Varenicline—Sinusitis—Memantine—Alzheimer's disease	0.000101	0.00104	CcSEcCtD
Varenicline—Discomfort—Galantamine—Alzheimer's disease	0.000101	0.00103	CcSEcCtD
Varenicline—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	9.97e-05	0.00102	CcSEcCtD
Varenicline—Dry mouth—Galantamine—Alzheimer's disease	9.97e-05	0.00102	CcSEcCtD
Varenicline—Epistaxis—Rivastigmine—Alzheimer's disease	9.95e-05	0.00102	CcSEcCtD
Varenicline—Tinnitus—Donepezil—Alzheimer's disease	9.94e-05	0.00102	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	9.92e-05	0.0015	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	9.9e-05	0.0015	CbGpPWpGaD
Varenicline—Sinusitis—Rivastigmine—Alzheimer's disease	9.89e-05	0.00102	CcSEcCtD
Varenicline—Bradycardia—Memantine—Alzheimer's disease	9.85e-05	0.00101	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	9.84e-05	0.00149	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	9.79e-05	0.00148	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	9.79e-05	0.00148	CbGpPWpGaD
Varenicline—Bradycardia—Rivastigmine—Alzheimer's disease	9.64e-05	0.000989	CcSEcCtD
Varenicline—Hypoaesthesia—Memantine—Alzheimer's disease	9.63e-05	0.000989	CcSEcCtD
Varenicline—Hallucination—Memantine—Alzheimer's disease	9.63e-05	0.000989	CcSEcCtD
Varenicline—Shock—Galantamine—Alzheimer's disease	9.61e-05	0.000987	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	9.6e-05	0.00146	CbGpPWpGaD
Varenicline—Nervous system disorder—Galantamine—Alzheimer's disease	9.58e-05	0.000984	CcSEcCtD
Varenicline—Thrombocytopenia—Galantamine—Alzheimer's disease	9.57e-05	0.000982	CcSEcCtD
Varenicline—Chills—Donepezil—Alzheimer's disease	9.56e-05	0.000982	CcSEcCtD
Varenicline—Urinary tract disorder—Memantine—Alzheimer's disease	9.56e-05	0.000981	CcSEcCtD
Varenicline—Tachycardia—Galantamine—Alzheimer's disease	9.54e-05	0.000979	CcSEcCtD
Varenicline—Oedema peripheral—Memantine—Alzheimer's disease	9.53e-05	0.000979	CcSEcCtD
Varenicline—Arrhythmia—Donepezil—Alzheimer's disease	9.52e-05	0.000978	CcSEcCtD
Varenicline—Connective tissue disorder—Memantine—Alzheimer's disease	9.51e-05	0.000976	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—GRIA1—Alzheimer's disease	9.5e-05	0.00144	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	9.5e-05	0.00144	CbGpPWpGaD
Varenicline—Skin disorder—Galantamine—Alzheimer's disease	9.49e-05	0.000974	CcSEcCtD
Varenicline—Urethral disorder—Memantine—Alzheimer's disease	9.49e-05	0.000974	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	9.48e-05	0.00144	CbGpPWpGaD
Varenicline—Hyperhidrosis—Galantamine—Alzheimer's disease	9.45e-05	0.00097	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	9.42e-05	0.00143	CbGpPWpGaD
Varenicline—Hallucination—Rivastigmine—Alzheimer's disease	9.42e-05	0.000967	CcSEcCtD
Varenicline—Hypoaesthesia—Rivastigmine—Alzheimer's disease	9.42e-05	0.000967	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	9.4e-05	0.00142	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	9.4e-05	0.00142	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	9.39e-05	0.00142	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CHAT—Alzheimer's disease	9.39e-05	0.00142	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GRIK2—Alzheimer's disease	9.39e-05	0.00142	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CRH—Alzheimer's disease	9.35e-05	0.00142	CbGpPWpGaD
Varenicline—Urinary tract disorder—Rivastigmine—Alzheimer's disease	9.35e-05	0.00096	CcSEcCtD
Varenicline—Mental disorder—Donepezil—Alzheimer's disease	9.34e-05	0.000959	CcSEcCtD
Varenicline—Oedema peripheral—Rivastigmine—Alzheimer's disease	9.33e-05	0.000957	CcSEcCtD
Varenicline—Visual impairment—Memantine—Alzheimer's disease	9.33e-05	0.000957	CcSEcCtD
Varenicline—Anorexia—Galantamine—Alzheimer's disease	9.31e-05	0.000956	CcSEcCtD
Varenicline—Connective tissue disorder—Rivastigmine—Alzheimer's disease	9.3e-05	0.000955	CcSEcCtD
Varenicline—Urethral disorder—Rivastigmine—Alzheimer's disease	9.28e-05	0.000953	CcSEcCtD
Varenicline—Erythema—Donepezil—Alzheimer's disease	9.28e-05	0.000953	CcSEcCtD
Varenicline—Malnutrition—Donepezil—Alzheimer's disease	9.28e-05	0.000953	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	9.17e-05	0.00139	CbGpPWpGaD
Varenicline—Erythema multiforme—Memantine—Alzheimer's disease	9.15e-05	0.000939	CcSEcCtD
Varenicline—Flatulence—Donepezil—Alzheimer's disease	9.14e-05	0.000939	CcSEcCtD
Varenicline—Hypotension—Galantamine—Alzheimer's disease	9.13e-05	0.000937	CcSEcCtD
Varenicline—Visual impairment—Rivastigmine—Alzheimer's disease	9.12e-05	0.000937	CcSEcCtD
Varenicline—Dysgeusia—Donepezil—Alzheimer's disease	9.09e-05	0.000933	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	9.08e-05	0.00138	CbGpPWpGaD
Varenicline—Eye disorder—Memantine—Alzheimer's disease	9.04e-05	0.000928	CcSEcCtD
Varenicline—Tinnitus—Memantine—Alzheimer's disease	9.02e-05	0.000926	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—CHRNB2—Alzheimer's disease	9e-05	0.00136	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	8.99e-05	0.00136	CbGpPWpGaD
Varenicline—Cardiac disorder—Memantine—Alzheimer's disease	8.98e-05	0.000922	CcSEcCtD
Varenicline—Back pain—Donepezil—Alzheimer's disease	8.97e-05	0.000921	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	8.97e-05	0.00136	CbGpPWpGaD
Varenicline—Erythema multiforme—Rivastigmine—Alzheimer's disease	8.95e-05	0.000919	CcSEcCtD
Varenicline—Muscle spasms—Donepezil—Alzheimer's disease	8.92e-05	0.000916	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	8.9e-05	0.000914	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	8.87e-05	0.00134	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NPS—Alzheimer's disease	8.86e-05	0.00134	CbGpPWpGaD
Varenicline—Eye disorder—Rivastigmine—Alzheimer's disease	8.85e-05	0.000908	CcSEcCtD
Varenicline—Insomnia—Galantamine—Alzheimer's disease	8.84e-05	0.000907	CcSEcCtD
Varenicline—Tinnitus—Rivastigmine—Alzheimer's disease	8.83e-05	0.000906	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	8.82e-05	0.00134	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	8.82e-05	0.00134	CbGpPWpGaD
Varenicline—Cardiac disorder—Rivastigmine—Alzheimer's disease	8.79e-05	0.000902	CcSEcCtD
Varenicline—Angiopathy—Memantine—Alzheimer's disease	8.78e-05	0.000901	CcSEcCtD
Varenicline—Vision blurred—Donepezil—Alzheimer's disease	8.74e-05	0.000898	CcSEcCtD
Varenicline—Immune system disorder—Memantine—Alzheimer's disease	8.74e-05	0.000897	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—SLC18A3—Alzheimer's disease	8.73e-05	0.00132	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	8.72e-05	0.00132	CbGpPWpGaD
Varenicline—Mediastinal disorder—Memantine—Alzheimer's disease	8.72e-05	0.000895	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—SLC6A4—Alzheimer's disease	8.69e-05	0.00132	CbGpPWpGaD
Varenicline—Tremor—Donepezil—Alzheimer's disease	8.69e-05	0.000892	CcSEcCtD
Varenicline—Somnolence—Galantamine—Alzheimer's disease	8.69e-05	0.000892	CcSEcCtD
Varenicline—Chills—Memantine—Alzheimer's disease	8.68e-05	0.000891	CcSEcCtD
Varenicline—Arrhythmia—Memantine—Alzheimer's disease	8.65e-05	0.000888	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	8.62e-05	0.00131	CbGpPWpGaD
Varenicline—Ill-defined disorder—Donepezil—Alzheimer's disease	8.61e-05	0.000884	CcSEcCtD
Varenicline—Dyspepsia—Galantamine—Alzheimer's disease	8.6e-05	0.000883	CcSEcCtD
Varenicline—Angiopathy—Rivastigmine—Alzheimer's disease	8.59e-05	0.000882	CcSEcCtD
Varenicline—Anaemia—Donepezil—Alzheimer's disease	8.58e-05	0.00088	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	8.53e-05	0.00129	CbGpPWpGaD
Varenicline—Mediastinal disorder—Rivastigmine—Alzheimer's disease	8.53e-05	0.000876	CcSEcCtD
Varenicline—Agitation—Donepezil—Alzheimer's disease	8.53e-05	0.000875	CcSEcCtD
Varenicline—Chills—Rivastigmine—Alzheimer's disease	8.49e-05	0.000872	CcSEcCtD
Varenicline—Decreased appetite—Galantamine—Alzheimer's disease	8.49e-05	0.000872	CcSEcCtD
Varenicline—Mental disorder—Memantine—Alzheimer's disease	8.48e-05	0.00087	CcSEcCtD
Varenicline—Arrhythmia—Rivastigmine—Alzheimer's disease	8.46e-05	0.000868	CcSEcCtD
Varenicline—Gastrointestinal disorder—Galantamine—Alzheimer's disease	8.44e-05	0.000866	CcSEcCtD
Varenicline—Malnutrition—Memantine—Alzheimer's disease	8.42e-05	0.000865	CcSEcCtD
Varenicline—Fatigue—Galantamine—Alzheimer's disease	8.42e-05	0.000865	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	8.37e-05	0.00127	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	8.37e-05	0.00127	CbGpPWpGaD
Varenicline—Malaise—Donepezil—Alzheimer's disease	8.37e-05	0.000859	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—GRIA1—Alzheimer's disease	8.36e-05	0.00127	CbGpPWpGaD
Varenicline—Constipation—Galantamine—Alzheimer's disease	8.36e-05	0.000858	CcSEcCtD
Varenicline—Vertigo—Donepezil—Alzheimer's disease	8.34e-05	0.000856	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	8.32e-05	0.00126	CbGpPWpGaD
Varenicline—Syncope—Donepezil—Alzheimer's disease	8.32e-05	0.000854	CcSEcCtD
Varenicline—Flatulence—Memantine—Alzheimer's disease	8.3e-05	0.000852	CcSEcCtD
Varenicline—Mental disorder—Rivastigmine—Alzheimer's disease	8.29e-05	0.000852	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	8.27e-05	0.00125	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—ACHE—Alzheimer's disease	8.27e-05	0.00125	CbGpPWpGaD
Varenicline—Dysgeusia—Memantine—Alzheimer's disease	8.25e-05	0.000847	CcSEcCtD
Varenicline—Erythema—Rivastigmine—Alzheimer's disease	8.24e-05	0.000846	CcSEcCtD
Varenicline—Malnutrition—Rivastigmine—Alzheimer's disease	8.24e-05	0.000846	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—CHRNA4—Alzheimer's disease	8.17e-05	0.00124	CbGpPWpGaD
Varenicline—Loss of consciousness—Donepezil—Alzheimer's disease	8.15e-05	0.000837	CcSEcCtD
Varenicline—Back pain—Memantine—Alzheimer's disease	8.15e-05	0.000837	CcSEcCtD
Varenicline—Flatulence—Rivastigmine—Alzheimer's disease	8.12e-05	0.000834	CcSEcCtD
Varenicline—Cough—Donepezil—Alzheimer's disease	8.1e-05	0.000831	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	8.09e-05	0.00123	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	8.08e-05	0.00122	CbGpPWpGaD
Varenicline—Dysgeusia—Rivastigmine—Alzheimer's disease	8.07e-05	0.000829	CcSEcCtD
Varenicline—Feeling abnormal—Galantamine—Alzheimer's disease	8.05e-05	0.000827	CcSEcCtD
Varenicline—Convulsion—Donepezil—Alzheimer's disease	8.04e-05	0.000825	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	8.02e-05	0.00122	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	8.02e-05	0.00122	CbGpPWpGaD
Varenicline—Hypertension—Donepezil—Alzheimer's disease	8.01e-05	0.000822	CcSEcCtD
Varenicline—Gastrointestinal pain—Galantamine—Alzheimer's disease	7.99e-05	0.00082	CcSEcCtD
Varenicline—Back pain—Rivastigmine—Alzheimer's disease	7.97e-05	0.000818	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	7.96e-05	0.00121	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CHRNA7—Alzheimer's disease	7.95e-05	0.0012	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GRIK1—Alzheimer's disease	7.95e-05	0.0012	CbGpPWpGaD
Varenicline—Vision blurred—Memantine—Alzheimer's disease	7.94e-05	0.000815	CcSEcCtD
Varenicline—Muscle spasms—Rivastigmine—Alzheimer's disease	7.92e-05	0.000813	CcSEcCtD
Varenicline—Myalgia—Donepezil—Alzheimer's disease	7.9e-05	0.000811	CcSEcCtD
Varenicline—Chest pain—Donepezil—Alzheimer's disease	7.9e-05	0.000811	CcSEcCtD
Varenicline—Arthralgia—Donepezil—Alzheimer's disease	7.9e-05	0.000811	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	7.89e-05	0.0012	CbGpPWpGaD
Varenicline—Tremor—Memantine—Alzheimer's disease	7.89e-05	0.00081	CcSEcCtD
Varenicline—Anxiety—Donepezil—Alzheimer's disease	7.87e-05	0.000808	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	7.86e-05	0.00119	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	7.83e-05	0.00119	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	7.83e-05	0.00119	CbGpPWpGaD
Varenicline—Ill-defined disorder—Memantine—Alzheimer's disease	7.82e-05	0.000802	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	7.81e-05	0.00118	CbGpPWpGaD
Varenicline—Discomfort—Donepezil—Alzheimer's disease	7.8e-05	0.000801	CcSEcCtD
Varenicline—Anaemia—Memantine—Alzheimer's disease	7.79e-05	0.000799	CcSEcCtD
Varenicline—Vision blurred—Rivastigmine—Alzheimer's disease	7.77e-05	0.000797	CcSEcCtD
Varenicline—Agitation—Memantine—Alzheimer's disease	7.74e-05	0.000795	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TF—Alzheimer's disease	7.74e-05	0.00117	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	7.74e-05	0.00117	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	7.73e-05	0.00117	CbGpPWpGaD
Varenicline—Dry mouth—Donepezil—Alzheimer's disease	7.73e-05	0.000793	CcSEcCtD
Varenicline—Body temperature increased—Galantamine—Alzheimer's disease	7.72e-05	0.000793	CcSEcCtD
Varenicline—Abdominal pain—Galantamine—Alzheimer's disease	7.72e-05	0.000793	CcSEcCtD
Varenicline—Tremor—Rivastigmine—Alzheimer's disease	7.72e-05	0.000793	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	7.68e-05	0.00116	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	7.68e-05	0.00116	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	7.66e-05	0.00116	CbGpPWpGaD
Varenicline—Ill-defined disorder—Rivastigmine—Alzheimer's disease	7.65e-05	0.000785	CcSEcCtD
Varenicline—Anaemia—Rivastigmine—Alzheimer's disease	7.62e-05	0.000782	CcSEcCtD
Varenicline—Malaise—Memantine—Alzheimer's disease	7.6e-05	0.00078	CcSEcCtD
Varenicline—Agitation—Rivastigmine—Alzheimer's disease	7.57e-05	0.000778	CcSEcCtD
Varenicline—Oedema—Donepezil—Alzheimer's disease	7.57e-05	0.000777	CcSEcCtD
Varenicline—Vertigo—Memantine—Alzheimer's disease	7.57e-05	0.000777	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	7.56e-05	0.00115	CbGpPWpGaD
Varenicline—Syncope—Memantine—Alzheimer's disease	7.55e-05	0.000776	CcSEcCtD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	7.55e-05	0.00114	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GRIK1—Alzheimer's disease	7.54e-05	0.00114	CbGpPWpGaD
Varenicline—Infection—Donepezil—Alzheimer's disease	7.52e-05	0.000772	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	7.48e-05	0.00113	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	7.46e-05	0.00113	CbGpPWpGaD
Varenicline—Shock—Donepezil—Alzheimer's disease	7.45e-05	0.000765	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	7.44e-05	0.00113	CbGpPWpGaD
Varenicline—Palpitations—Memantine—Alzheimer's disease	7.44e-05	0.000764	CcSEcCtD
Varenicline—Malaise—Rivastigmine—Alzheimer's disease	7.43e-05	0.000763	CcSEcCtD
Varenicline—Nervous system disorder—Donepezil—Alzheimer's disease	7.43e-05	0.000762	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	7.42e-05	0.00113	CbGpPWpGaD
Varenicline—Thrombocytopenia—Donepezil—Alzheimer's disease	7.41e-05	0.000761	CcSEcCtD
Varenicline—Vertigo—Rivastigmine—Alzheimer's disease	7.4e-05	0.00076	CcSEcCtD
Varenicline—Loss of consciousness—Memantine—Alzheimer's disease	7.4e-05	0.00076	CcSEcCtD
Varenicline—Syncope—Rivastigmine—Alzheimer's disease	7.39e-05	0.000759	CcSEcCtD
Varenicline—Cough—Memantine—Alzheimer's disease	7.35e-05	0.000755	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	7.34e-05	0.00111	CbGpPWpGaD
Varenicline—Hyperhidrosis—Donepezil—Alzheimer's disease	7.32e-05	0.000752	CcSEcCtD
Varenicline—Convulsion—Memantine—Alzheimer's disease	7.3e-05	0.000749	CcSEcCtD
Varenicline—Palpitations—Rivastigmine—Alzheimer's disease	7.28e-05	0.000748	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—ACHE—Alzheimer's disease	7.28e-05	0.0011	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	7.28e-05	0.0011	CbGpPWpGaD
Varenicline—Hypertension—Memantine—Alzheimer's disease	7.27e-05	0.000747	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—NGFR—Alzheimer's disease	7.26e-05	0.0011	CbGpPWpGaD
Varenicline—Loss of consciousness—Rivastigmine—Alzheimer's disease	7.24e-05	0.000744	CcSEcCtD
Varenicline—Anorexia—Donepezil—Alzheimer's disease	7.22e-05	0.000741	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—BCHE—Alzheimer's disease	7.2e-05	0.00109	CbGpPWpGaD
Varenicline—Hypersensitivity—Galantamine—Alzheimer's disease	7.2e-05	0.000739	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—CHRNA4—Alzheimer's disease	7.19e-05	0.00109	CbGpPWpGaD
Varenicline—Cough—Rivastigmine—Alzheimer's disease	7.19e-05	0.000738	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	7.18e-05	0.00109	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	7.17e-05	0.00109	CbGpPWpGaD
Varenicline—Chest pain—Memantine—Alzheimer's disease	7.17e-05	0.000736	CcSEcCtD
Varenicline—Arthralgia—Memantine—Alzheimer's disease	7.17e-05	0.000736	CcSEcCtD
Varenicline—Myalgia—Memantine—Alzheimer's disease	7.17e-05	0.000736	CcSEcCtD
Varenicline—Anxiety—Memantine—Alzheimer's disease	7.15e-05	0.000734	CcSEcCtD
Varenicline—Convulsion—Rivastigmine—Alzheimer's disease	7.14e-05	0.000733	CcSEcCtD
Varenicline—Hypertension—Rivastigmine—Alzheimer's disease	7.12e-05	0.00073	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	7.1e-05	0.00108	CbGpPWpGaD
Varenicline—Discomfort—Memantine—Alzheimer's disease	7.09e-05	0.000727	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SST—Alzheimer's disease	7.08e-05	0.00107	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	7.08e-05	0.00107	CbGpPWpGaD
Varenicline—Hypotension—Donepezil—Alzheimer's disease	7.08e-05	0.000726	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	7.06e-05	0.00107	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—DLG4—Alzheimer's disease	7.03e-05	0.00107	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	7.03e-05	0.00106	CbGpPWpGaD
Varenicline—Chest pain—Rivastigmine—Alzheimer's disease	7.02e-05	0.00072	CcSEcCtD
Varenicline—Arthralgia—Rivastigmine—Alzheimer's disease	7.02e-05	0.00072	CcSEcCtD
Varenicline—Myalgia—Rivastigmine—Alzheimer's disease	7.02e-05	0.00072	CcSEcCtD
Varenicline—Dry mouth—Memantine—Alzheimer's disease	7.01e-05	0.00072	CcSEcCtD
Varenicline—Asthenia—Galantamine—Alzheimer's disease	7.01e-05	0.00072	CcSEcCtD
Varenicline—Anxiety—Rivastigmine—Alzheimer's disease	6.99e-05	0.000718	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	6.97e-05	0.000715	CcSEcCtD
Varenicline—Discomfort—Rivastigmine—Alzheimer's disease	6.93e-05	0.000712	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	6.9e-05	0.000708	CcSEcCtD
Varenicline—Oedema—Memantine—Alzheimer's disease	6.88e-05	0.000706	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—GRIN2B—Alzheimer's disease	6.87e-05	0.00104	CbGpPWpGaD
Varenicline—Dry mouth—Rivastigmine—Alzheimer's disease	6.86e-05	0.000704	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	6.86e-05	0.00104	CbGpPWpGaD
Varenicline—Insomnia—Donepezil—Alzheimer's disease	6.85e-05	0.000703	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	6.84e-05	0.00104	CbGpPWpGaD
Varenicline—Infection—Memantine—Alzheimer's disease	6.83e-05	0.000701	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	6.82e-05	0.00103	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	6.82e-05	0.00103	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—PLCB1—Alzheimer's disease	6.79e-05	0.00103	CbGpPWpGaD
Varenicline—Shock—Memantine—Alzheimer's disease	6.76e-05	0.000694	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	6.76e-05	0.00102	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GRIK2—Alzheimer's disease	6.76e-05	0.00102	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CHAT—Alzheimer's disease	6.76e-05	0.00102	CbGpPWpGaD
Varenicline—Dyspnoea—Donepezil—Alzheimer's disease	6.75e-05	0.000693	CcSEcCtD
Varenicline—Nervous system disorder—Memantine—Alzheimer's disease	6.74e-05	0.000692	CcSEcCtD
Varenicline—Somnolence—Donepezil—Alzheimer's disease	6.73e-05	0.000691	CcSEcCtD
Varenicline—Thrombocytopenia—Memantine—Alzheimer's disease	6.73e-05	0.000691	CcSEcCtD
Varenicline—Oedema—Rivastigmine—Alzheimer's disease	6.73e-05	0.000691	CcSEcCtD
Varenicline—Tachycardia—Memantine—Alzheimer's disease	6.71e-05	0.000689	CcSEcCtD
Varenicline—Diarrhoea—Galantamine—Alzheimer's disease	6.69e-05	0.000686	CcSEcCtD
Varenicline—Infection—Rivastigmine—Alzheimer's disease	6.68e-05	0.000686	CcSEcCtD
Varenicline—Skin disorder—Memantine—Alzheimer's disease	6.68e-05	0.000686	CcSEcCtD
Varenicline—Dyspepsia—Donepezil—Alzheimer's disease	6.67e-05	0.000684	CcSEcCtD
Varenicline—Hyperhidrosis—Memantine—Alzheimer's disease	6.65e-05	0.000682	CcSEcCtD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	6.64e-05	0.00101	CbGpPWpGaD
Varenicline—Shock—Rivastigmine—Alzheimer's disease	6.62e-05	0.000679	CcSEcCtD
Varenicline—Nervous system disorder—Rivastigmine—Alzheimer's disease	6.6e-05	0.000677	CcSEcCtD
Varenicline—Thrombocytopenia—Rivastigmine—Alzheimer's disease	6.59e-05	0.000676	CcSEcCtD
Varenicline—Decreased appetite—Donepezil—Alzheimer's disease	6.58e-05	0.000676	CcSEcCtD
Varenicline—Tachycardia—Rivastigmine—Alzheimer's disease	6.56e-05	0.000674	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	6.56e-05	0.000994	CbGpPWpGaD
Varenicline—Anorexia—Memantine—Alzheimer's disease	6.55e-05	0.000673	CcSEcCtD
Varenicline—Gastrointestinal disorder—Donepezil—Alzheimer's disease	6.54e-05	0.000671	CcSEcCtD
Varenicline—Skin disorder—Rivastigmine—Alzheimer's disease	6.53e-05	0.000671	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	6.53e-05	0.00099	CbGpPWpGaD
Varenicline—Fatigue—Donepezil—Alzheimer's disease	6.53e-05	0.00067	CcSEcCtD
Varenicline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	6.5e-05	0.000668	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	6.5e-05	0.000985	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	6.49e-05	0.000984	CbGpPWpGaD
Varenicline—Pain—Donepezil—Alzheimer's disease	6.48e-05	0.000665	CcSEcCtD
Varenicline—Constipation—Donepezil—Alzheimer's disease	6.48e-05	0.000665	CcSEcCtD
Varenicline—Dizziness—Galantamine—Alzheimer's disease	6.46e-05	0.000663	CcSEcCtD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	6.46e-05	0.000979	CbGpPWpGaD
Varenicline—Hypotension—Memantine—Alzheimer's disease	6.42e-05	0.00066	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	6.42e-05	0.000972	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CHAT—Alzheimer's disease	6.41e-05	0.000972	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GRIK2—Alzheimer's disease	6.41e-05	0.000972	CbGpPWpGaD
Varenicline—Anorexia—Rivastigmine—Alzheimer's disease	6.41e-05	0.000658	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—BCHE—Alzheimer's disease	6.34e-05	0.000961	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TF—Alzheimer's disease	6.31e-05	0.000956	CbGpPWpGaD
Varenicline—Hypotension—Rivastigmine—Alzheimer's disease	6.29e-05	0.000645	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Memantine—Alzheimer's disease	6.26e-05	0.000643	CcSEcCtD
Varenicline—Feeling abnormal—Donepezil—Alzheimer's disease	6.24e-05	0.000641	CcSEcCtD
Varenicline—Insomnia—Memantine—Alzheimer's disease	6.22e-05	0.000638	CcSEcCtD
Varenicline—Vomiting—Galantamine—Alzheimer's disease	6.21e-05	0.000638	CcSEcCtD
Varenicline—Gastrointestinal pain—Donepezil—Alzheimer's disease	6.19e-05	0.000636	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—DLG4—Alzheimer's disease	6.19e-05	0.000938	CbGpPWpGaD
Varenicline—Rash—Galantamine—Alzheimer's disease	6.16e-05	0.000632	CcSEcCtD
Varenicline—Dermatitis—Galantamine—Alzheimer's disease	6.16e-05	0.000632	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—GRIK1—Alzheimer's disease	6.15e-05	0.000932	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CHRNA7—Alzheimer's disease	6.15e-05	0.000932	CbGpPWpGaD
Varenicline—Dyspnoea—Memantine—Alzheimer's disease	6.13e-05	0.000629	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	6.13e-05	0.000629	CcSEcCtD
Varenicline—Headache—Galantamine—Alzheimer's disease	6.12e-05	0.000628	CcSEcCtD
Varenicline—Somnolence—Memantine—Alzheimer's disease	6.11e-05	0.000628	CcSEcCtD
Varenicline—Insomnia—Rivastigmine—Alzheimer's disease	6.08e-05	0.000625	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	6.08e-05	0.000922	CbGpPWpGaD
Varenicline—Dyspepsia—Memantine—Alzheimer's disease	6.05e-05	0.000621	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—GRIN2B—Alzheimer's disease	6.05e-05	0.000917	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GRIA1—Alzheimer's disease	6.02e-05	0.000913	CbGpPWpGaD
Varenicline—Urticaria—Donepezil—Alzheimer's disease	6.02e-05	0.000618	CcSEcCtD
Varenicline—Dyspnoea—Rivastigmine—Alzheimer's disease	6e-05	0.000616	CcSEcCtD
Varenicline—Abdominal pain—Donepezil—Alzheimer's disease	5.99e-05	0.000615	CcSEcCtD
Varenicline—Body temperature increased—Donepezil—Alzheimer's disease	5.99e-05	0.000615	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	5.98e-05	0.000907	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—PLCB1—Alzheimer's disease	5.98e-05	0.000907	CbGpPWpGaD
Varenicline—Somnolence—Rivastigmine—Alzheimer's disease	5.98e-05	0.000614	CcSEcCtD
Varenicline—Decreased appetite—Memantine—Alzheimer's disease	5.98e-05	0.000614	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	5.96e-05	0.000903	CbGpPWpGaD
Varenicline—Gastrointestinal disorder—Memantine—Alzheimer's disease	5.94e-05	0.000609	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	5.93e-05	0.000899	CbGpPWpGaD
Varenicline—Fatigue—Memantine—Alzheimer's disease	5.93e-05	0.000609	CcSEcCtD
Varenicline—Dyspepsia—Rivastigmine—Alzheimer's disease	5.92e-05	0.000608	CcSEcCtD
Varenicline—Constipation—Memantine—Alzheimer's disease	5.88e-05	0.000604	CcSEcCtD
Varenicline—Pain—Memantine—Alzheimer's disease	5.88e-05	0.000604	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	5.85e-05	0.000887	CbGpPWpGaD
Varenicline—Decreased appetite—Rivastigmine—Alzheimer's disease	5.85e-05	0.0006	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	5.82e-05	0.000881	CbGpPWpGaD
Varenicline—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	5.81e-05	0.000596	CcSEcCtD
Varenicline—Nausea—Galantamine—Alzheimer's disease	5.8e-05	0.000596	CcSEcCtD
Varenicline—Fatigue—Rivastigmine—Alzheimer's disease	5.8e-05	0.000595	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	5.78e-05	0.000877	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	5.77e-05	0.000875	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SST—Alzheimer's disease	5.77e-05	0.000875	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	5.77e-05	0.000875	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	5.76e-05	0.000873	CbGpPWpGaD
Varenicline—Constipation—Rivastigmine—Alzheimer's disease	5.75e-05	0.00059	CcSEcCtD
Varenicline—Pain—Rivastigmine—Alzheimer's disease	5.75e-05	0.00059	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—PRKCG—Alzheimer's disease	5.75e-05	0.000872	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GRIA1—Alzheimer's disease	5.72e-05	0.000866	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CHRNB2—Alzheimer's disease	5.7e-05	0.000865	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	5.69e-05	0.000862	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	5.68e-05	0.000862	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5.67e-05	0.00086	CbGpPWpGaD
Varenicline—Feeling abnormal—Memantine—Alzheimer's disease	5.67e-05	0.000582	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	5.65e-05	0.000857	CbGpPWpGaD
Varenicline—Gastrointestinal pain—Memantine—Alzheimer's disease	5.62e-05	0.000577	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	5.62e-05	0.000852	CbGpPWpGaD
Varenicline—Hypersensitivity—Donepezil—Alzheimer's disease	5.58e-05	0.000573	CcSEcCtD
Varenicline—Feeling abnormal—Rivastigmine—Alzheimer's disease	5.54e-05	0.000569	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	5.53e-05	0.000838	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	5.52e-05	0.000836	CbGpPWpGaD
Varenicline—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	5.5e-05	0.000565	CcSEcCtD
Varenicline—Urticaria—Memantine—Alzheimer's disease	5.46e-05	0.000561	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	5.44e-05	0.000824	CbGpPWpGaD
Varenicline—Body temperature increased—Memantine—Alzheimer's disease	5.44e-05	0.000558	CcSEcCtD
Varenicline—Abdominal pain—Memantine—Alzheimer's disease	5.44e-05	0.000558	CcSEcCtD
Varenicline—Asthenia—Donepezil—Alzheimer's disease	5.43e-05	0.000558	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—CHRNB2—Alzheimer's disease	5.41e-05	0.00082	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	5.39e-05	0.000818	CbGpPWpGaD
Varenicline—Pruritus—Donepezil—Alzheimer's disease	5.36e-05	0.00055	CcSEcCtD
Varenicline—Urticaria—Rivastigmine—Alzheimer's disease	5.34e-05	0.000549	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	5.33e-05	0.000809	CbGpPWpGaD
Varenicline—Abdominal pain—Rivastigmine—Alzheimer's disease	5.32e-05	0.000546	CcSEcCtD
Varenicline—Body temperature increased—Rivastigmine—Alzheimer's disease	5.32e-05	0.000546	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	5.29e-05	0.000802	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	5.28e-05	0.000801	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	5.25e-05	0.000795	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—ACHE—Alzheimer's disease	5.24e-05	0.000794	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GRIK2—Alzheimer's disease	5.23e-05	0.000792	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CHAT—Alzheimer's disease	5.23e-05	0.000792	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	5.22e-05	0.000791	CbGpPWpGaD
Varenicline—Diarrhoea—Donepezil—Alzheimer's disease	5.18e-05	0.000532	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—CHRNA4—Alzheimer's disease	5.18e-05	0.000785	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	5.07e-05	0.000769	CbGpPWpGaD
Varenicline—Hypersensitivity—Memantine—Alzheimer's disease	5.07e-05	0.00052	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—PRKCG—Alzheimer's disease	5.02e-05	0.000762	CbGpPWpGaD
Varenicline—Dizziness—Donepezil—Alzheimer's disease	5.01e-05	0.000514	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5e-05	0.000757	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—ACHE—Alzheimer's disease	4.97e-05	0.000754	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—LEP—Alzheimer's disease	4.96e-05	0.000751	CbGpPWpGaD
Varenicline—Hypersensitivity—Rivastigmine—Alzheimer's disease	4.96e-05	0.000509	CcSEcCtD
Varenicline—Asthenia—Memantine—Alzheimer's disease	4.93e-05	0.000506	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—CHRNA4—Alzheimer's disease	4.92e-05	0.000745	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	4.91e-05	0.000744	CbGpPWpGaD
Varenicline—Pruritus—Memantine—Alzheimer's disease	4.86e-05	0.000499	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.86e-05	0.000736	CbGpPWpGaD
Varenicline—Asthenia—Rivastigmine—Alzheimer's disease	4.83e-05	0.000495	CcSEcCtD
Varenicline—Vomiting—Donepezil—Alzheimer's disease	4.81e-05	0.000494	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	4.78e-05	0.000725	CbGpPWpGaD
Varenicline—Rash—Donepezil—Alzheimer's disease	4.77e-05	0.00049	CcSEcCtD
Varenicline—Dermatitis—Donepezil—Alzheimer's disease	4.77e-05	0.00049	CcSEcCtD
Varenicline—Pruritus—Rivastigmine—Alzheimer's disease	4.76e-05	0.000489	CcSEcCtD
Varenicline—Headache—Donepezil—Alzheimer's disease	4.74e-05	0.000487	CcSEcCtD
Varenicline—Diarrhoea—Memantine—Alzheimer's disease	4.7e-05	0.000483	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	4.69e-05	0.000711	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GRIA1—Alzheimer's disease	4.66e-05	0.000706	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NOS2—Alzheimer's disease	4.62e-05	0.0007	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	4.61e-05	0.000699	CbGpPWpGaD
Varenicline—Diarrhoea—Rivastigmine—Alzheimer's disease	4.6e-05	0.000472	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—BCHE—Alzheimer's disease	4.56e-05	0.000692	CbGpPWpGaD
Varenicline—Dizziness—Memantine—Alzheimer's disease	4.55e-05	0.000467	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	4.54e-05	0.000688	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	4.5e-05	0.000682	CbGpPWpGaD
Varenicline—Nausea—Donepezil—Alzheimer's disease	4.5e-05	0.000462	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	4.46e-05	0.000676	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—DLG4—Alzheimer's disease	4.46e-05	0.000675	CbGpPWpGaD
Varenicline—Dizziness—Rivastigmine—Alzheimer's disease	4.45e-05	0.000457	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	4.43e-05	0.000672	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—PRKCG—Alzheimer's disease	4.42e-05	0.000671	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CHRNB2—Alzheimer's disease	4.41e-05	0.000669	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	4.4e-05	0.000666	CbGpPWpGaD
Varenicline—Vomiting—Memantine—Alzheimer's disease	4.37e-05	0.000449	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—GRIN2B—Alzheimer's disease	4.35e-05	0.00066	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	4.35e-05	0.000659	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CALM1—Alzheimer's disease	4.35e-05	0.000659	CbGpPWpGaD
Varenicline—Rash—Memantine—Alzheimer's disease	4.34e-05	0.000445	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—BCHE—Alzheimer's disease	4.33e-05	0.000657	CbGpPWpGaD
Varenicline—Dermatitis—Memantine—Alzheimer's disease	4.33e-05	0.000445	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—PPARG—Alzheimer's disease	4.32e-05	0.000655	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—PLCB1—Alzheimer's disease	4.31e-05	0.000653	CbGpPWpGaD
Varenicline—Headache—Memantine—Alzheimer's disease	4.31e-05	0.000442	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	4.31e-05	0.000653	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—GSK3B—Alzheimer's disease	4.29e-05	0.000651	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	4.28e-05	0.000648	CbGpPWpGaD
Varenicline—Vomiting—Rivastigmine—Alzheimer's disease	4.28e-05	0.000439	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.28e-05	0.000648	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CREB1—Alzheimer's disease	4.26e-05	0.000646	CbGpPWpGaD
Varenicline—Rash—Rivastigmine—Alzheimer's disease	4.24e-05	0.000435	CcSEcCtD
Varenicline—Dermatitis—Rivastigmine—Alzheimer's disease	4.24e-05	0.000435	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—DLG4—Alzheimer's disease	4.23e-05	0.000641	CbGpPWpGaD
Varenicline—Headache—Rivastigmine—Alzheimer's disease	4.21e-05	0.000433	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	4.16e-05	0.00063	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	4.13e-05	0.000627	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GRIN2B—Alzheimer's disease	4.13e-05	0.000626	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	4.1e-05	0.000621	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—PLCB1—Alzheimer's disease	4.09e-05	0.00062	CbGpPWpGaD
Varenicline—Nausea—Memantine—Alzheimer's disease	4.08e-05	0.000419	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—ACHE—Alzheimer's disease	4.05e-05	0.000614	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	4e-05	0.000606	CbGpPWpGaD
Varenicline—Nausea—Rivastigmine—Alzheimer's disease	4e-05	0.00041	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	3.95e-05	0.000598	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	3.89e-05	0.000589	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	3.87e-05	0.000587	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	3.86e-05	0.000585	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CALM1—Alzheimer's disease	3.83e-05	0.00058	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	3.82e-05	0.000579	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CREB1—Alzheimer's disease	3.72e-05	0.000564	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	3.7e-05	0.000561	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	3.64e-05	0.000551	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	3.6e-05	0.000545	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	3.56e-05	0.00054	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—BCHE—Alzheimer's disease	3.53e-05	0.000535	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—DLG4—Alzheimer's disease	3.45e-05	0.000522	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	3.41e-05	0.000517	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GRIN2B—Alzheimer's disease	3.37e-05	0.000511	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—PLCB1—Alzheimer's disease	3.33e-05	0.000505	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.28e-05	0.000497	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CREB1—Alzheimer's disease	3.28e-05	0.000497	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	3.22e-05	0.000487	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—PRKCG—Alzheimer's disease	3.19e-05	0.000483	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	3.17e-05	0.00048	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	3.08e-05	0.000467	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—PRKCG—Alzheimer's disease	3.02e-05	0.000458	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.92e-05	0.000443	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	2.91e-05	0.00044	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—MAPK8—Alzheimer's disease	2.9e-05	0.000439	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.81e-05	0.000426	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	2.78e-05	0.000422	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CALM1—Alzheimer's disease	2.76e-05	0.000418	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.64e-05	0.000401	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.64e-05	0.0004	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CALM1—Alzheimer's disease	2.62e-05	0.000396	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—PRKCG—Alzheimer's disease	2.46e-05	0.000374	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.38e-05	0.000361	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CREB1—Alzheimer's disease	2.36e-05	0.000358	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.27e-05	0.000344	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	2.24e-05	0.000339	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CREB1—Alzheimer's disease	2.24e-05	0.000339	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.16e-05	0.000327	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.15e-05	0.000326	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CALM1—Alzheimer's disease	2.13e-05	0.000323	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—TP53—Alzheimer's disease	2.02e-05	0.000306	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.92e-05	0.000291	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—IL6—Alzheimer's disease	1.85e-05	0.000281	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.83e-05	0.000277	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CREB1—Alzheimer's disease	1.82e-05	0.000277	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.56e-05	0.000237	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.55e-05	0.000235	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.26e-05	0.000191	CbGpPWpGaD
